These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1573036)
1. Plasma drug level and clinical response. Cooper TB; Volavka J; Czobor P J Clin Psychopharmacol; 1992 Apr; 12(2):134-6. PubMed ID: 1573036 [No Abstract] [Full Text] [Related]
2. The relationship between plasma haloperidol concentrations and clinical results. Palao DJ; Araúxo A; Haro JM; Brunet M; Bernardo M Arch Gen Psychiatry; 1996 Dec; 53(12):1167-9. PubMed ID: 8956684 [No Abstract] [Full Text] [Related]
3. Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidol. Chang WH; Shieh YS; Liu HC; Jann MW; Chien CP Eur Neuropsychopharmacol; 1994 Jun; 4(2):119-26. PubMed ID: 7919941 [TBL] [Abstract][Full Text] [Related]
4. Haloperidol plasma levels and acute clinical change in schizophrenia. Coryell W; Kelly M; Perry PJ; Miller DD J Clin Psychopharmacol; 1990 Dec; 10(6):397-402. PubMed ID: 2286709 [TBL] [Abstract][Full Text] [Related]
5. Plasma haloperidol and reduced haloperidol concentrations in a geriatric population. Chang WH; Jann MW; Chiang TS; Lin HN; Hu WH; Chien CP Neuropsychobiology; 1996; 33(1):12-6. PubMed ID: 8821369 [TBL] [Abstract][Full Text] [Related]
6. Low plasma reduced haloperidol/haloperidol ratios in Chinese patients. Chang WH; Chen TY; Lee CF; Hu WH; Yeh EK Biol Psychiatry; 1987 Nov; 22(11):1406-8. PubMed ID: 3663790 [No Abstract] [Full Text] [Related]
7. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state. Jibiki I; Kubota T; Fujimoto K; Sakamoto H; Hasegawa M; Furuta H; Yamaguchi N Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878 [No Abstract] [Full Text] [Related]
8. Coadministration of fluvoxamine increases serum concentrations of haloperidol. Daniel DG; Randolph C; Jaskiw G; Handel S; Williams T; Abi-Dargham A; Shoaf S; Egan M; Elkashef A; Liboff S J Clin Psychopharmacol; 1994 Oct; 14(5):340-3. PubMed ID: 7806690 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic protocol for predicting plasma haloperidol concentrations. Miller DD; Perry PJ; Kelly MW; Coryell WH; Arndt SV J Clin Psychopharmacol; 1990 Jun; 10(3):207-12. PubMed ID: 2376619 [TBL] [Abstract][Full Text] [Related]
10. RBC and plasma levels of haloperidol and clinical response in schizophrenia. Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432 [TBL] [Abstract][Full Text] [Related]
11. Haloperidol plasma levels and clinical response: a therapeutic window relationship. Van Putten T; Marder SR; Mintz J; Poland RE Am J Psychiatry; 1992 Apr; 149(4):500-5. PubMed ID: 1554036 [TBL] [Abstract][Full Text] [Related]
12. Plasma haloperidol levels: clinical response and fancy mathematics. Van Putten T; Marder SR; Mintz J Arch Gen Psychiatry; 1985 Aug; 42(8):835-8. PubMed ID: 4015328 [No Abstract] [Full Text] [Related]
13. Serum prolactin as a correlate of clinical response to haloperidol. Van Putten T; Marder SR; Mintz J J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154 [TBL] [Abstract][Full Text] [Related]
14. The interpretation of plasma haloperidol concentrations. Kirch DG; Bigelow LB; Wyatt RJ Arch Gen Psychiatry; 1985 Aug; 42(8):838-40. PubMed ID: 4015329 [No Abstract] [Full Text] [Related]
15. Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients. Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Lane HY; Jann MW Biol Psychiatry; 1993 Apr; 33(7):557-9. PubMed ID: 8513043 [No Abstract] [Full Text] [Related]
16. Haloperidol: therapeutic window in schizophrenia. Palao DJ; Arauxo A; Brunet M; Bernardo M; Haro JM; Ferrer J; Gonzalez-Monclus E J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684 [TBL] [Abstract][Full Text] [Related]